Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Melanoma | 7 | 2022 | 5508 | 0.510 |
Why?
|
| Audiovisual Aids | 1 | 2012 | 92 | 0.410 |
Why?
|
| Mutagenesis | 2 | 2012 | 1263 | 0.340 |
Why?
|
| Ultraviolet Rays | 2 | 2012 | 1060 | 0.320 |
Why?
|
| Molecular Conformation | 1 | 2009 | 561 | 0.300 |
Why?
|
| Databases, Protein | 1 | 2008 | 383 | 0.280 |
Why?
|
| Skin Neoplasms | 3 | 2022 | 5691 | 0.270 |
Why?
|
| Melanocytes | 3 | 2022 | 515 | 0.270 |
Why?
|
| Computer Graphics | 1 | 2007 | 360 | 0.250 |
Why?
|
| Protein Conformation | 2 | 2011 | 4009 | 0.240 |
Why?
|
| Publishing | 1 | 2009 | 833 | 0.200 |
Why?
|
| Oxygen | 1 | 2012 | 4189 | 0.190 |
Why?
|
| Mutation | 12 | 2022 | 29777 | 0.180 |
Why?
|
| Biochemistry | 2 | 2012 | 113 | 0.170 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2013 | 2039 | 0.170 |
Why?
|
| Models, Molecular | 4 | 2012 | 5445 | 0.150 |
Why?
|
| Software | 2 | 2008 | 4440 | 0.150 |
Why?
|
| Sequence Alignment | 2 | 2012 | 2256 | 0.140 |
Why?
|
| Endometrial Neoplasms | 2 | 2016 | 1350 | 0.140 |
Why?
|
| Endometrial Hyperplasia | 1 | 2016 | 97 | 0.130 |
Why?
|
| Abdominal Neoplasms | 1 | 2016 | 292 | 0.120 |
Why?
|
| Uveal Neoplasms | 1 | 2017 | 310 | 0.120 |
Why?
|
| Pelvic Neoplasms | 1 | 2016 | 254 | 0.120 |
Why?
|
| Genome-Wide Association Study | 2 | 2012 | 12259 | 0.120 |
Why?
|
| Genome, Human | 3 | 2017 | 4418 | 0.110 |
Why?
|
| Ribosomal Proteins | 1 | 2014 | 360 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 2 | 2014 | 5867 | 0.100 |
Why?
|
| Encyclopedias as Topic | 1 | 2011 | 20 | 0.100 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2012 | 237 | 0.100 |
Why?
|
| Visual Cortex | 1 | 2019 | 1136 | 0.100 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 376 | 0.090 |
Why?
|
| Sunlight | 1 | 2012 | 325 | 0.090 |
Why?
|
| Genetic Code | 1 | 2010 | 154 | 0.090 |
Why?
|
| Evolution, Molecular | 2 | 2016 | 1940 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 749 | 0.090 |
Why?
|
| Online Systems | 1 | 2011 | 184 | 0.090 |
Why?
|
| Oncogenes | 2 | 2013 | 1265 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2019 | 3591 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 528 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 3583 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2017 | 2123 | 0.090 |
Why?
|
| Genetic Heterogeneity | 1 | 2013 | 733 | 0.090 |
Why?
|
| Amino Acid Sequence | 2 | 2012 | 13809 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2177 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 5170 | 0.080 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2012 | 581 | 0.080 |
Why?
|
| Telomerase | 1 | 2013 | 731 | 0.080 |
Why?
|
| Sulfonamides | 2 | 2014 | 1938 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2012 | 4033 | 0.070 |
Why?
|
| Open Reading Frames | 1 | 2010 | 811 | 0.070 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2014 | 808 | 0.070 |
Why?
|
| Proteins | 3 | 2011 | 6098 | 0.070 |
Why?
|
| Polyesters | 1 | 2008 | 362 | 0.070 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 6363 | 0.070 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2110 | 0.060 |
Why?
|
| Teaching | 1 | 2012 | 1173 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2014 | 2750 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9440 | 0.060 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 2419 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2014 | 8430 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2014 | 13691 | 0.050 |
Why?
|
| Oximes | 2 | 2013 | 311 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 2944 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2014 | 2945 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2014 | 2248 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2008 | 3847 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 8939 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2013 | 5532 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 18107 | 0.040 |
Why?
|
| Base Sequence | 1 | 2010 | 12798 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2012 | 19232 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 4803 | 0.040 |
Why?
|
| DNA | 1 | 2012 | 7295 | 0.040 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2017 | 33 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2008 | 1880 | 0.040 |
Why?
|
| Imidazoles | 2 | 2013 | 1206 | 0.040 |
Why?
|
| Humans | 16 | 2022 | 743811 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9648 | 0.040 |
Why?
|
| Phylogeny | 2 | 2016 | 2796 | 0.030 |
Why?
|
| Internet | 1 | 2008 | 3058 | 0.030 |
Why?
|
| Binding Sites | 2 | 2014 | 6111 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6773 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2014 | 188 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 5230 | 0.030 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2013 | 94 | 0.030 |
Why?
|
| DNA Replication Timing | 1 | 2013 | 35 | 0.030 |
Why?
|
| raf Kinases | 1 | 2013 | 122 | 0.030 |
Why?
|
| Organoids | 1 | 2019 | 701 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11524 | 0.030 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2013 | 96 | 0.030 |
Why?
|
| Brain | 1 | 2019 | 26345 | 0.030 |
Why?
|
| Indazoles | 1 | 2014 | 290 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2012 | 98 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 799 | 0.030 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2013 | 334 | 0.030 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2014 | 502 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2013 | 318 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2013 | 13112 | 0.020 |
Why?
|
| Pyrimidinones | 1 | 2013 | 370 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 646 | 0.020 |
Why?
|
| Information Management | 1 | 2011 | 101 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 980 | 0.020 |
Why?
|
| Sample Size | 1 | 2013 | 841 | 0.020 |
Why?
|
| Information Services | 1 | 2011 | 244 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2014 | 2034 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 2010 | 198 | 0.020 |
Why?
|
| Pyridones | 1 | 2013 | 711 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2019 | 3492 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 1284 | 0.020 |
Why?
|
| Ethylamines | 1 | 2008 | 15 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 19894 | 0.020 |
Why?
|
| Methacrylates | 1 | 2008 | 106 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2011 | 595 | 0.020 |
Why?
|
| Markov Chains | 1 | 2010 | 968 | 0.020 |
Why?
|
| X-Rays | 1 | 2008 | 301 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 914 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 16674 | 0.020 |
Why?
|
| Gels | 1 | 2008 | 425 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 2924 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2014 | 4931 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2008 | 454 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2019 | 6188 | 0.020 |
Why?
|
| Monte Carlo Method | 1 | 2010 | 1254 | 0.020 |
Why?
|
| Indoles | 1 | 2013 | 1841 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 1861 | 0.020 |
Why?
|
| Surface Properties | 1 | 2008 | 1168 | 0.020 |
Why?
|
| Artifacts | 1 | 2013 | 1904 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4204 | 0.020 |
Why?
|
| Neoplasms | 1 | 2013 | 21675 | 0.010 |
Why?
|
| User-Computer Interface | 1 | 2011 | 1431 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 2938 | 0.010 |
Why?
|
| Cell Count | 1 | 2008 | 1855 | 0.010 |
Why?
|
| Middle Aged | 5 | 2017 | 213241 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 4183 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 4848 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2942 | 0.010 |
Why?
|
| Information Dissemination | 1 | 2011 | 1099 | 0.010 |
Why?
|
| Protein Binding | 1 | 2014 | 9377 | 0.010 |
Why?
|
| DNA Damage | 1 | 2012 | 2429 | 0.010 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 1181 | 0.010 |
Why?
|
| Aged | 4 | 2017 | 163178 | 0.010 |
Why?
|
| Female | 6 | 2017 | 380020 | 0.010 |
Why?
|
| Cattle | 1 | 2008 | 3917 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2008 | 1503 | 0.010 |
Why?
|
| Animals | 4 | 2019 | 168660 | 0.010 |
Why?
|
| Signal Transduction | 2 | 2014 | 23398 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 2217 | 0.010 |
Why?
|
| RNA | 1 | 2010 | 2748 | 0.010 |
Why?
|
| Genomics | 1 | 2016 | 5714 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7793 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 57744 | 0.010 |
Why?
|
| Male | 5 | 2017 | 349776 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13273 | 0.010 |
Why?
|
| Biocompatible Materials | 1 | 2008 | 1731 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2014 | 6535 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13869 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7719 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 4251 | 0.010 |
Why?
|
| Phenotype | 1 | 2014 | 16361 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 3850 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2014 | 12209 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 9582 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 81154 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 56392 | 0.010 |
Why?
|
| Adult | 2 | 2017 | 213889 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2012 | 40545 | 0.010 |
Why?
|
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(44)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_